Heavy menstrual bleeding: assessment and management

National Institute for Health and Care Excellence

Between 20 and 30% of women in England and Wales of reproductive age were affected by heavy menstrual bleeding (HMB) in 2011. Although HMB is not associated with significant mortality and considered unimportant by some healthcare professionals, the condition can interfere with women’s physical, emotional, social, and material quality of life. It is estimated to be the fourth most common reason for referral to gynaecological services.

This updated Guidelines summary covers diagnosis of HMB, information for patients, and possible pharmaceutical interventions.

Register to view this page

Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:

  • GuidelinesinPractice.co.uk
  • Guidelines.co.uk
  • GuidelinesforNurses.co.uk


Log in

Need help? Email us